KYTX
Kyverna Therapeutics (KYTX)
$30
About Kyverna Therapeutics (KYTX)
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Details
Daily high
$8.56
Daily low
$8.15
Price at open
$8.30
52 Week High
$13.67
52 Week Low
$2.52
Market cap
490.6M
Dividend yield
0.00%
Volume
911,840
Avg. volume
757,947
P/E ratio
-2.46
Kyverna Therapeutics News
Details
Daily high
$8.56
Daily low
$8.15
Price at open
$8.30
52 Week High
$13.67
52 Week Low
$2.52
Market cap
490.6M
Dividend yield
0.00%
Volume
911,840
Avg. volume
757,947
P/E ratio
-2.46